Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Cash flow from operating activities:
Net loss	$ (1,116,402)	$ (1,115,221)	$ (2,527,524)	$ (4,468,170)	$ (6,833,568)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			57,512	44,118
Vested stock options and warrants			320,334	440,117
Equity instruments issued for management and consulting			(6,667)	111,917
Amortization of debt discount			219,097	87,853
Penalty on debt provision			10,031
Loss on Sales of Equipment			16,917
(Gain) loss on valuation of equity-linked instruments				(11,599)
Changes in assets and liabilities:
Accounts receivable			43,353	(141,359)
Inventories			130,477	(193,445)
Prepaid expense and other assets			(23,208)	(88,362)
Accounts payable			(1,056,006)	515,710
Accrued expenses			(1,845,850)	624,530
Deferred Revenue			24,180	(64,000)
Net cash used in operating activities:			(4,637,354)	(3,142,690)
Cash flow from investing activities:
Purchase of fixed assets				(102,954)
Purchase of intangibles			(23,739)	(19,346)
Net cash used in investing activities			(23,739)	(122,300)
Cash flow from financing activities:
Proceeds from long-term and convertible debt			250,000	1,500,000
Principal payments on debt			(933,074)	(305,000)
Net proceeds from issuance of preferred stock			18,950	2,055,000
Net proceeds from issuance of common stock			13,041,930	157,081
Net cash provided by financing activities			12,377,806	3,407,081
Net increase in cash			7,716,713	142,091
Cash at beginning of period			16,384	101,953	101,953
Cash at end of period	$ 7,733,097	$ 244,044	7,733,097	244,044	$ 16,384
Non cash transactions:
Common stock issued for accrued interest/bonus				694,500
Common stock issued to satisfy debt			$ 483,478	$ 80,000